trans-Pterostilbene.

NR raises the NAD pool that sirtuin enzymes consume, and pterostilbene acts as a stilbene activator of the same sirtuin signalling. Supplying the cofactor and the activator together is the reasoning behind the long-standing pairing.

NMN feeds the same NAD pool by a step closer to the final product. Pterostilbene sits on the consuming side of that pool as a sirtuin-directed stilbene.

Pterostilbene is resveratrol with two of its hydroxyls replaced by methoxy groups, which raises lipid solubility and slows conjugation clearance. They act on the same stilbene targets with different exposure profiles.

Quercetin occupies the sulfotransferase and UDP-glucuronosyltransferase capacity that also conjugates stilbenes. With those routes busy, more of the stilbene stays unconjugated in circulation.

Piperine inhibits intestinal and hepatic glucuronidation, the main route that clears stilbenes and other polyphenols. Co-dosing raises how much of the parent molecule survives first pass.

Spermidine promotes autophagy by inhibiting acetyltransferase activity, while sirtuin-directed stilbenes reach the same process through deacetylation. The two arrive at one endpoint from opposite enzyme families.

Stilbenes dampen platelet aggregation and long-chain omega-3 fatty acids shift eicosanoid balance the same way. At generous intakes of both, the effect on normal clotting adds up.

Nattokinase acts on fibrin while stilbenes act on platelet aggregation, two separate stages of the same sequence. Stacking them compounds the effect.

After a stilbene donates a hydrogen it is left as a phenoxyl radical. Ascorbate in the aqueous phase reduces it back to the active phenol, the same service it performs for other polyphenols.

Sulforaphane modifies cysteine residues on Keap1 directly, releasing Nrf2 to induce phase II enzymes. Stilbenes including pterostilbene are described as activating the same axis by a different upstream route. Convergence on one transcription factor means the effects may add, and the readouts in this literature are enzyme induction markers rather than clinical endpoints.

Nrf2 activation raises the expression of glutamate-cysteine ligase, the rate-limiting glutathione synthesis enzyme, but cysteine supply is what that enzyme runs on. NAC provides the cysteine. Pairing an inducer with a substrate addresses two different limits on the same output.

Glutathione is the cell's main thiol buffer and the endpoint most Nrf2-activator studies measure. Oral glutathione absorption is limited and contested, which caps what the pairing can achieve. The claim here is about a redox marker, not a health outcome.

Alpha-lipoic acid cycles between oxidised and reduced states and is itself described as an Nrf2 activator, so it overlaps with pterostilbene both as a redox agent and as a signalling one. The two reach different compartments, lipoate being both water and lipid soluble and pterostilbene strongly lipophilic. Overlapping pathways mean overlapping effects, not doubled ones.

Alpha-tocopherol terminates lipid peroxidation chains within membranes, which is the compartment pterostilbene's two methoxy groups make it partition into. The two act on the same lipid phase by different chemistry, tocopherol as a chain terminator and the stilbene largely through gene expression. Reported endpoints are peroxidation markers.

Coenzyme Q10 shuttles electrons in the inner mitochondrial membrane and limits peroxidation there, while stilbenes are studied for their effects on mitochondrial biogenesis signalling. One supplies a redox carrier and the other is described as changing how many carriers the cell builds. Both lines are mechanistic.

Urolithin A is studied for its effect on mitophagy, the clearance of damaged mitochondria, and stilbene work centres on AMPK and sirtuin-linked mitochondrial biogenesis. Clearance and biogenesis are complementary halves of mitochondrial turnover. This is a mechanistic pairing with no combination trial behind it.

Berberine activates AMPK by inhibiting mitochondrial complex I and raising the AMP to ATP ratio, and stilbenes are reported to reach AMPK through sirtuin-linked signalling. Two routes into one kinase can add. Berberine also lowers glucose markers, so anyone monitoring blood glucose should watch the combination.

Curcumin and pterostilbene are both electrophilic dietary polyphenols reported to activate Nrf2 and restrain NF-kappa-B-linked transcription. Both are also poorly water-soluble and depend on a fat-containing meal. The shared solubility problem is as practical as the shared pathway.

EGCG and pterostilbene are both cleared largely by UDP-glucuronosyltransferase and sulfotransferase conjugation, and dietary polyphenols competitively inhibit those enzymes. Co-ingestion can therefore raise the exposure of either compound above what each produces alone. That is a pharmacokinetic interaction, and it cuts both ways rather than being a benefit by default.

Luteolin inhibits sulfotransferase and glucuronidation steps in vitro, the same phase II reactions that clear pterostilbene. Blocking clearance changes circulating parent compound rather than changing what the compound does. Combining conjugation inhibitors stacks that pharmacokinetic effect unpredictably.

Apigenin inhibits several conjugating and cytochrome P450 enzymes at concentrations reached in vitro. Any of those would alter pterostilbene exposure from a fixed dose. Whether that happens at ordinary oral doses in people has not been measured, so the row is a flag rather than a finding.

Grape seed proanthocyanidins and stilbenes occur together in the same botanical source and are studied on overlapping vascular and redox pathways. Combining them mirrors the botanical mixture rather than isolating one molecule. Most of the supporting work is in vitro or in animals.

Pine bark proanthocyanidins are studied for effects on endothelial nitric oxide signalling, a pathway stilbene reviews also address. Two agents on the same endothelial pathway may add. Both lines of evidence rest largely on markers such as flow-mediated dilation rather than clinical events.

Astaxanthin sits across the membrane bilayer and quenches singlet oxygen there, which is the compartment a dimethoxylated stilbene distributes into. The two are chemically unrelated and act by different routes in the same physical space. Endpoints in this literature are oxidation markers.

Silymarin flavonolignans both induce phase II enzymes and inhibit glucuronidation in vitro, so they can push pterostilbene exposure in either direction depending on dose and timing. Predicting the net effect from mechanism alone is not possible. Named here so the interaction is visible rather than assumed absent.

Melatonin scavenges radicals directly and is consumed doing so, whereas pterostilbene works largely by inducing the cell's own antioxidant enzymes. A direct scavenger plus an inducer of scavenging capacity address different parts of the same problem. Both are lipophilic enough to reach membranes and mitochondria.

Pterostilbene's two methoxy groups make it markedly more lipophilic and less water-soluble than resveratrol, so uptake depends on lipid solubilisation in the gut. A medium-chain triglyceride vehicle provides that lipid phase and stimulates bile flow. This is an absorption argument, not a claim about what the compound then does.

Sirtuins consume NAD+ as a co-substrate for every deacetylation reaction they catalyse, and niacinamide is one of the salvage-pathway precursors that keeps the NAD+ pool filled. Stilbene work centres on sirtuin-linked signalling, which cannot run without that pool. Niacinamide is also a direct product inhibitor of sirtuins at high concentration, so the relationship is not simply one-directional.

Every sirtuin deacetylation reaction cleaves NAD+, making the cellular NAD+ concentration a hard limit on sirtuin flux. Any agent studied through sirtuin signalling is therefore bounded by NAD+ availability. Stated as cofactor biochemistry, not as a supplementation outcome.

Berry anthocyanins and stilbenes travel together in the diet and are studied on overlapping vascular and redox endpoints. Pterostilbene itself was first characterised from plant sources of this type. The pairing reproduces a dietary matrix and rests on preclinical work.